CN107969541A - 一种心肌肽压片糖果 - Google Patents
一种心肌肽压片糖果 Download PDFInfo
- Publication number
- CN107969541A CN107969541A CN201711207065.3A CN201711207065A CN107969541A CN 107969541 A CN107969541 A CN 107969541A CN 201711207065 A CN201711207065 A CN 201711207065A CN 107969541 A CN107969541 A CN 107969541A
- Authority
- CN
- China
- Prior art keywords
- myocardium
- pressed candy
- natto
- ribose
- ferment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 43
- 210000004165 myocardium Anatomy 0.000 title claims abstract description 36
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 22
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 31
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 22
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims abstract description 18
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims abstract description 18
- 235000013557 nattō Nutrition 0.000 claims abstract description 18
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 17
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 17
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 15
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- -1 oligoisomaltose Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 11
- 230000035764 nutrition Effects 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 6
- 208000031225 myocardial ischemia Diseases 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 6
- 231100000765 toxin Toxicity 0.000 abstract description 6
- 230000000747 cardiac effect Effects 0.000 abstract description 4
- 208000019622 heart disease Diseases 0.000 abstract description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 description 16
- 239000000047 product Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000009525 Myocarditis Diseases 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- CDVZCUKHEYPEQS-BURFZZGCSA-N (2r,3r,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@@H](O)C=O CDVZCUKHEYPEQS-BURFZZGCSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 208000035239 Synesthesia Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940086319 nattokinase Drugs 0.000 description 1
- 108010073682 nattokinase Proteins 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种心肌肽压片糖果，属于保健食品技术领域。本发明的技术方案是：所述心肌肽压片糖果含有心肌肽粉、D‑核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖。本发明压片糖果，有效的营养心肌，防治各种心脏疾病及心肌缺血的发生；还具有养颜排毒的功效，方便人们在任何地方随意的食用。
Description
【技术领域】
本发明涉及一种心肌肽压片糖果，属于保健食品技术领域。
【背景技术】
我们知道，食品应该多样化，但随着现代人生活节奏的加快，生活压力和工作压力等问题，人们没有过多的时间和精力将食品准备的多种多样。尤其是上班族，多以快餐代替，无暇顾及营养的多样性。且一些人群会出现肠胃功能紊乱、脸上长痘、便秘等影响健康的现代病；中老年人还会出现心脏方面的疾病，严重影响人们的生存质量和经济生活。
长期的肠胃功能紊乱、及心脏方面的疾病，会引发实质性变化，如人体器官功能的退化，甚至会影响生命。如果疾病找上门来的时候，恐怕是是为时已晚，如果能在日常生活中为人们提供一种保健糖果，能随时、随地的食用，既能够满足口感，又能够增加人体抵抗力，达到延年益寿的目的，是人们非常期望的事情。
【发明内容】
【发明目的】
本发明的目的是提供一种心肌肽营养压片糖果，方便人们在任何地方随意的食用。
【技术方案】
一种心肌肽压片糖果，含有心肌肽粉、D-核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖。
本发明优选的技术方案：一种心肌肽压片糖果，含有心肌肽粉1份，D-核糖1-1.5份，大豆肽粉1-3份，纳豆0.4-0.8份，酵素0.3-0.7份，维生素C 0.1-0.3份，、麦芽糊精1-2份，低聚异麦芽糖1-2份。
本发明优选的技术方案：一种心肌肽压片糖果，每1000片中，含有心肌肽粉100g，D-核糖100-150g，大豆肽粉100-300g，纳豆40-80g，酵素30-70g，维生素C 10-30g，麦芽糊精100-200g，低聚异麦芽糖100-200g。
本发明优选的技术方案：一种心肌肽压片糖果，每1000片中，含有心肌肽粉100g，D-核糖120g，大豆肽粉200g，纳豆60g，酵素50g，维生素C 20g，麦芽糊精150g，低聚异麦芽糖150g。
本发明心肌肽压片糖果的制备方法，包括以下步骤：
步骤1、心肌肽粉、D-核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖分别过100目筛。
步骤2、称取配方量的第一步过筛的心肌肽粉、D-核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖，混匀。
步骤3、压片，铝塑、包装。
心肌肽粉：含有营养心肌的必须的各种营养，可以有效的营养心肌，防治各种心脏疾病及心肌缺血的发生。
D-核糖(D-ribose)，是重要的五碳单糖，是核糖核酸(RNA)、ATP的重要组成物质，是生命代谢最基本的能量来源之一，在心脏和骨骼肌代谢中起关键作用。
大豆肽粉是一种由2-6个氨基酸组成的、分子量在200-800Dalton的混合肽产品。与原蛋白相比，大豆肽粉具有很好的水溶性，能在pH2-10的任何酸碱条件下完全溶解。
与原蛋白和同组成的氨基酸制剂相比，大豆肽粉更易被人体吸收，它可不经胃肠消化，直接进入小肠被吸收，而且不受身体状况所影响。豆肽粉含有多种生物活性肽，具有多种生理活性，包括抗氧化、降血压、降低胆固醇、降血脂、抗疲劳、增强免疫等。作为一种新型多功能营养配料，大豆肽粉可广泛地用于保健食品、婴幼儿食品、运动食品、发酵制品及临床营养制剂等。
除了营养丰富、容易吸收外，还具有抗高血压、降低胆固醇、抗血栓形成，改善脂质代谢，防止动脉硬化，增强人体体能和肌肉力量，促进肌红细胞复原，消除疲劳、促进钙、磷和其它微量元素吸收，可以形成大豆肽络合钙直接进入血液，沉积在骨中，不需要维生素D的参与，达到提高骨骼强度的功效；肽还能促进大脑发育、提高记忆力，还具有增强吞噬细胞和B细胞的活力，增强免疫功能，具有抗癌、抗衰老、保护表皮细胞、防止黑色素沉着、消除氧化自由基，起血液清道夫作用；可促进细胞繁殖，保护肝脏，防止肝硬化，并有助于肝功能的恢复，对糖尿病人具有医疗和预防作用；并可预防老年性痴呆和胆结石的发生。
纳豆是黄豆经纳豆菌发酵制成的豆制品，纳豆发酵过程中产生的纳豆激酶，具有良好的抗血栓功能。
酵素是一种霉，能够有效地提升身体代谢能力，快速有效分解、燃烧多余脂肪；增强身体的排毒功能，能促使多余的毒素被排出体外；酵素可以清洁肠道，减少有害菌，改善便秘，排除毒素，从而上皮肤变更更光滑细致。
维生素C具有强的抗氧化作用，是保证人体健康的必须维生素。
麦芽糊精广泛应用于饮料、冷冻食品、糖果、麦片、乳制品、保健品等行业，还可应用于纺织、日化、医药生产中。麦芽糊精易被人体吸收，可用于运动员、病人、婴幼儿等功能奶粉，如无蔗糖奶粉、运动饮料中。使产品体积膨胀、不易结块、速溶、冲调性好，提高营养比价。
低聚异麦芽糖对人体内有益的双歧杆菌有强大的增殖作用，净化肠道，促进肠蠕动，防止和解除便秘及腹泻，抑制体内有害菌的繁殖和有毒腐败物质的产生。对分泌体内多种毒素的产气荚膜梭状芽胞杆菌有明显抑制作用，增强免疫力、降低胆固醇和血脂，促进老年人对钙质的吸收，是驻防老年人骨质疏松的有效营养补剂，还可阻断蔗糖被变异链球菌分解，抑制蛀牙。
本发明所述心肌肽压片糖果，常温存放。成年人每日食用量2-6片为宜。
【有益效果】
本发明产品经过几种组分的合理配伍，在保证原有效用的前提下，产生了协同作用。本发明所述心肌肽压片糖果，可以有效的营养心肌，防治各种心脏疾病及心肌缺血的发生；还具有养颜排毒的功效；以及促进肠蠕动，防止和解除便秘及腹泻功效；还具有营养骨骼、强身健体的作用；本发明心肌肽营养压片糖果，方便人们在任何地方随意的食用。
【实施例与试验例】
本发明实施例仅用于说明本发明的技术方案及使用效果。
实施例1、心肌肽粉100g，D-核糖100g，大豆肽粉300g，纳豆40g，酵素70g，维生素C10g，麦芽糊精200g，低聚异麦芽糖100g，按技术方案所述制备方法制备1000片。
实施例2、心肌肽粉100g，D-核糖150g，大豆肽粉100，纳豆80g，酵素30g，维生素C30g，麦芽糊精100g，低聚异麦芽糖200g，按技术方案所述制备方法制备1000片。
实施例3、心肌肽粉100g，D-核糖120g，大豆肽粉200g，纳豆60g，酵素50g，维生素C20g，麦芽糊精150g，低聚异麦芽糖150g，按技术方案所述制备方法制备1000片。
试验例1、写字楼办公人员，原来均不同程度的患有便秘、腹胀、脸上长痘人员90人，随机分为3组，分别食用本发明实施例1-3的产品，每日3次，每次1片，服用第20天，所有人员的便秘、腹胀症状消失，且脸上的豆豆也消失了，共同感觉身体轻松愉快，面容有光泽。
试验例2、门诊确诊心肌炎、心肌缺血人员80人，随机分为4组，实验组在服用原药品的基础上分别食用本发明实施例1-3的产品，对照组仅服用原药品，每日4次，每次1片，1个月后复检，实验组较对照组恢复的快且好，心肌炎患者全部恢复，心肌缺血患者全部好转。而对照组心肌缺血患者维持病情没有发展。
Claims (5)
1.一种心肌肽压片糖果，其特征在于，含有心肌肽粉、D-核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖。
2.按照权利要求1所述心肌肽压片糖果，其特征在于，含有心肌肽粉1份，D-核糖1-1.5份，大豆肽粉1-3份，纳豆0.4-0.8份，酵素0.3-0.7份，维生素C 0.1-0.3份，、麦芽糊精1-2份，低聚异麦芽糖1-2份。
3.按照权利要求1所述心肌肽压片糖果，其特征在于，每1000片中，含有心肌肽粉100g，D-核糖100-150g，大豆肽粉100-300g，纳豆40-80g，酵素30-70g，维生素C 10-30g，麦芽糊精100-200g，低聚异麦芽糖100-200g。
4.按照权利要求1所述心肌肽压片糖果，其特征在于，每1000片中，含有心肌肽粉100g，D-核糖120g，大豆肽粉200g，纳豆60g，酵素50g，维生素C 20g，麦芽糊精150g，低聚异麦芽糖150g。
5.权利要求1所述心肌肽压片糖果的制备方法，其特征在于，包括以下步骤：
步骤1、心肌肽粉、D-核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖分别过100目筛；
步骤2、称取配方量的第一步过筛的心肌肽粉、D-核糖、大豆肽粉、纳豆、酵素、维生素C、麦芽糊精、低聚异麦芽糖，混匀；
步骤3、压片，铝塑、包装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711207065.3A CN107969541A (zh) | 2017-11-27 | 2017-11-27 | 一种心肌肽压片糖果 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711207065.3A CN107969541A (zh) | 2017-11-27 | 2017-11-27 | 一种心肌肽压片糖果 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107969541A true CN107969541A (zh) | 2018-05-01 |
Family
ID=62011883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711207065.3A Pending CN107969541A (zh) | 2017-11-27 | 2017-11-27 | 一种心肌肽压片糖果 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107969541A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108378188A (zh) * | 2018-05-29 | 2018-08-10 | 南京财经大学 | 一种发芽糙米大豆肽压片糖果及其制备方法 |
| CN110122639A (zh) * | 2019-06-21 | 2019-08-16 | 澳优乳业（中国）有限公司 | 一种排毒降脂的压片糖果及其制备方法 |
| CN110916174A (zh) * | 2019-12-16 | 2020-03-27 | 北京神飞航天应用技术研究院 | 一种提高体质功能的宇航级复合营养制剂 |
| CN115381013A (zh) * | 2021-05-24 | 2022-11-25 | 陕西罗麻丹医药有限公司 | 一种能够营养心肌细胞的固体饮料及其制备方法 |
-
2017
- 2017-11-27 CN CN201711207065.3A patent/CN107969541A/zh active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108378188A (zh) * | 2018-05-29 | 2018-08-10 | 南京财经大学 | 一种发芽糙米大豆肽压片糖果及其制备方法 |
| CN108378188B (zh) * | 2018-05-29 | 2021-07-20 | 南京财经大学 | 一种发芽糙米大豆肽压片糖果及其制备方法 |
| CN110122639A (zh) * | 2019-06-21 | 2019-08-16 | 澳优乳业（中国）有限公司 | 一种排毒降脂的压片糖果及其制备方法 |
| CN110916174A (zh) * | 2019-12-16 | 2020-03-27 | 北京神飞航天应用技术研究院 | 一种提高体质功能的宇航级复合营养制剂 |
| CN115381013A (zh) * | 2021-05-24 | 2022-11-25 | 陕西罗麻丹医药有限公司 | 一种能够营养心肌细胞的固体饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102224891B (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
| CN107969541A (zh) | 一种心肌肽压片糖果 | |
| CN104432037B (zh) | 抗氧化的保健营养组合物及其制备方法与应用 | |
| CN110338402A (zh) | 一种复合益生菌粉及其制备方法 | |
| CN104855967A (zh) | 肥胖、减脂手术非全营养配方食品 | |
| CN104738624A (zh) | 一种神经衰弱、健忘失眠的营养保健食品 | |
| CN108308488A (zh) | D-源生肽固体饮料 | |
| CN105029393A (zh) | 儿童医学配方食品 | |
| CN1315418C (zh) | 黑木耳燕麦螺旋藻即冲饮品及其制备方法 | |
| CN104839695A (zh) | 炎性肠病非全营养配方食品 | |
| CN108308597A (zh) | 一种营养不良专用型临床营养配方及其制备方法 | |
| CN104856000A (zh) | 失眠非全营养配方食品 | |
| CN110214942A (zh) | 一种甲亢专用型医学营养配方及其制备方法 | |
| CN104839698A (zh) | 心血管疾病非全营养配方食品 | |
| CN104855978A (zh) | 抗衰老非全营养配方食品 | |
| CN104855972A (zh) | 妇女延更调理非全营养配方食品 | |
| CN104855970A (zh) | 高血压非全营养配方食品 | |
| CN104839679A (zh) | 心脏病医学配方食品 | |
| CN104855963A (zh) | 产妇产后调理非全营养配方食品 | |
| CN103621871B (zh) | 一种复合氨基酸保健品及其制备方法 | |
| CN104839699A (zh) | 心脏病非全营养配方食品 | |
| CN104855969A (zh) | 肝病非全营养配方食品 | |
| CN104839682A (zh) | 妇女延更调理医学配方食品 | |
| CN107136490A (zh) | 一种肽虫草保健品 | |
| CN104855966A (zh) | 儿童非全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180501 |